GLP-1/exendin-4 facilitates beta-cell neogenesis in rat and human pancreatic ducts

Diabetes Res Clin Pract. 2006 Jul;73(1):107-10. doi: 10.1016/j.diabres.2005.11.007. Epub 2006 Jan 6.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / drug therapy
  • Diabetes Mellitus, Experimental / pathology
  • Exenatide
  • Glucagon-Like Peptide 1 / pharmacology*
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / drug effects
  • Male
  • Pancreatic Ducts / cytology*
  • Pancreatic Ducts / drug effects
  • Peptides / pharmacology*
  • Peptides / therapeutic use
  • Rats
  • Receptors, Glucagon / biosynthesis
  • Venoms / pharmacology*
  • Venoms / therapeutic use

Substances

  • GLP1R protein, human
  • Glp1r protein, rat
  • Glucagon-Like Peptide-1 Receptor
  • Peptides
  • Receptors, Glucagon
  • Venoms
  • Glucagon-Like Peptide 1
  • Exenatide